NOVORAPID VIAL

About

Novorapid Vial contains insulin aspart, a rapid-acting insulin analogue indicated for the treatment of diabetes mellitus in adults, adolescents, and children aged 1 year and above. Insulin aspart is designed to mimic the natural physiological insulin response to a meal, with a rapid onset of action (10-20 minutes) and a relatively short duration (3-5 hours). It is typically administered immediately before a meal (0-10 minutes prior) to cover the postprandial glucose rise, or shortly after a meal if necessary. Its rapid action helps to prevent hyperglycemia that occurs after eating, making it an essential component of intensive insulin regimens, often used in conjunction with a long-acting or intermediate-acting insulin.

Patients using Novorapid must be thoroughly educated on proper injection technique, the importance of timing injections relative to meals, and consistent blood glucose monitoring. Dose adjustments are often required based on carbohydrate intake, physical activity, and current blood glucose levels. As with all insulin products, the most common side effect is hypoglycemia, which can be severe if not managed promptly. Regular consultation with a healthcare professional is crucial to optimize dosing, monitor for adverse effects, and ensure safe and effective diabetes management. The goal of therapy is to achieve optimal glycemic control while minimizing the risk of hypoglycemia.

Uses

• Treatment of Type 1 Diabetes Mellitus
• Management of Type 2 Diabetes Mellitus
• Controls post-meal blood glucose spikes
• Used in intensive insulin regimens

Directions For Use

Inject subcutaneously 0-10 minutes before a meal, or shortly after. Rotate injection sites to prevent lipodystrophy.

Benefits

• Rapid onset of action for mealtime glucose control
• Flexible dosing around meal times
• Helps prevent postprandial hyperglycemia
• Essential for intensive insulin therapy
• Can be used in insulin pumps
• Improves overall glycemic control

Side Effects

• Hypoglycemia (low blood sugar)
• Injection site reactions (pain, redness, swelling)
• Lipodystrophy (fat accumulation or atrophy)
• Weight gain
• Allergic reactions
• Peripheral edema
• Pruritus
• Rash
• Urticaria
• Blurred vision (temporary)
• Diabetic retinopathy worsening (temporary)
• Hypokalemia (low potassium)

Safety Measures

• Alcohol - Alcohol can lower blood sugar and increase the risk of hypoglycemia. Use with caution and monitor glucose levels.
• Pregnancy - Consult a doctor. Insulin requirements may change during pregnancy. Close monitoring is essential.
• Breastfeeding - Generally considered safe, but consult a healthcare provider. Insulin does not pass into breast milk in significant amounts.
• Liver - Use with caution in hepatic impairment; insulin requirements may be altered. Monitor glucose levels closely.
• Kidney - Use with caution in renal impairment; insulin requirements may be altered. Monitor glucose levels closely.
• Lung - No specific contraindications for lung conditions.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.